Impact of Federal Regulatory Changes on Clinical Pharmacology and Drug Development: the Common Rule and the 21st Century Cures Act

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|58|3|281-285

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.58, Iss.3, 2018-03, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

House passes 21st century cures act: Legislation would boost NIH funding, speed drug development

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4101-4102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacology and the Catalysis of Regulatory Science: Opportunities for the Advancement of Drug Development and Evaluation

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 6, 2013-06 ,pp. : 515-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transporters in Drug Development and Clinical Pharmacology

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 3-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery

By Rowntree Rebecca K   McNeish John D  

Regenerative Medicine, Vol. 5, Iss. 4, 2010-07 ,pp. : 557-568

Future Medicine

Access to resources Recommend Favorite

The promise of 21st century professionalism: Regulatory reform and integrated care

By  

Journal of Interprofessional Care, Vol. 21, Iss. 3, 2007-06 ,pp. : 233-239

Informa Healthcare

Access to resources Recommend Favorite